The iron transporter ferroportin can also function as a manganese exporter  by Madejczyk, Michael S. & Ballatori, Nazzareno
Biochimica et Biophysica Acta 1818 (2012) 651–657
Contents lists available at SciVerse ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamemThe iron transporter ferroportin can also function as a manganese exporter
Michael S. Madejczyk ⁎, Nazzareno Ballatori
Department of Environmental Medicine, University of Rochester School of Medicine, Rochester, NY 14642, USAAbbreviations: DMT1, divalent metal transporter-1
SLC40A1
⁎ Corresponding author at: Department of Biology,
Hutchinson Hall, Box 270211, Rochester, NY 14627,
fax: +1 585 275 2070.
E-mail address: Mike_Madejczyk@urmc.rochester.ed
0005-2736/$ – see front matter © 2011 Elsevier B.V. All
doi:10.1016/j.bbamem.2011.12.002a b s t r a c ta r t i c l e i n f oArticle history:
Received 12 May 2011
Received in revised form 28 November 2011
Accepted 2 December 2011
Available online 8 December 2011
Keywords:
Ferroportin
FPN1
Manganese
Metal export
Divalent metal transporter
Xenopus laevis oocytesThe present study examined the hypothesis that the iron exporter ferroportin (FPN1/SLC40A1) can also me-
diate cellular export of the essential trace element manganese, using Xenopus laevis oocytes expressing
human FPN1. When compared to oocytes expressing only the divalent metal transporter-1 (DMT1/
NRAMP2), 54Mn accumulation was lower in oocytes also expressing FPN1. FPN1-expressing oocytes exported
more 54Mn than control oocytes (26.6±0.6% versus 7.1±0.5%, respectively, over 4 h at pH 7.4 when pre-
loaded with approximately 16 μM 54Mn); however, there was no difference in 54Mn uptake between control
and FPN1-expressing oocytes. FPN1-mediated Mn export was concentration dependent and could be partial-
ly cis-inhibited by 100 μM Fe, Co, and Ni, but not by Rb. In addition, Mn export ability was signiﬁcantly re-
duced when the extracellular pH was reduced from 7.4 to 5.5, and when Na+ was substituted with K+ in
the incubation media. These results indicate that Mn is a substrate for FPN1, and that this export process is
inhibited by a low extracellular pH and by incubation in a high K+ medium, indicating the involvement of
transmembrane ion gradients in FPN1-mediated transport.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Manganese (Mn) is an essential trace element that is utilized in a
number of important cellular processes; however, excess Mn can also
be quite toxic [1]. Manganese neurotoxicity has been reported in oc-
cupationally exposed workers that have been chronically exposed to
aerosols or dusts that contain high levels (>5 mg Mn/m3) of manga-
nese [2–4]. Under most conditions, Mn homeostasis is maintained in
a large part via the actions of the intestine and liver: the intestine
acts as an initial control of Mn levels by absorbing a variable amount
of dietary Mn (1–5%), the main source of exposure [5], whereas he-
patic biliary excretion serves as the major route of elimination for ex-
cess manganese [6]; although the speciﬁc transporters involved
remain largely unknown.
In general, cellular manganese uptake appears to be mediated in
part via similar mechanisms as iron [7–9]. This is not unexpected, as
Mn and Fe share many similar physical and chemical properties. For
example, these transition metals have similar atomic masses (54.94
and 55.85 amu, for Mn and Fe respectively), radii (127 pm for Mn
versus 125 pm for Fe), and electron structure ([Ar] 4s2 3d5 for Mn
and [Ar] 4s2 3d6 for Fe). Both elements have similar electronegativity/NRAMP2; FPN1, ferroportin/
University of Rochester, 437
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rights reserved.(1.55 and 1.83) and ionization energies (717 and 763 kJ/mol for the
1st ionization), and exist in multiple oxidation states.
Indeed, Mn2+ is a known substrate for the divalent metal
transporter-1 (Dmt1/Slc11A2/Nramp2), a highly conserved uptake
transporter that utilizes the proton gradient to drive the uptake of a
number of divalent metals, including Fe, Mn, Cd, Co, Cu, Zn, and to a
lesser extent Ni and Pb [8,10]. The importance of Dmt1 in Fe and
Mn homeostasis has been demonstrated utilizing the microcytic ane-
mia mouse and the Belgrade (b) rat, which have a defect in Dmt1
transport activity and display reduced Fe and Mn uptake [11–13].
However, Dmt1 may not be essential for Mn transport, as suggested
in a study by Crossgrove and Yokel [14] using in situ brain perfusion
of b/b, +/b, and +/+ rats, which indicated the presence of other
Mn transport mechanisms, although these have not yet been identi-
ﬁed. Iron status can also inﬂuence Mn homeostasis. For example,
iron deﬁciency is a risk factor for metal toxicity and an inverse rela-
tionship exists between dietary Fe and absorption and distribution
of several other metals, including Mn [15–17]. Once taken up into
cells, Mn can be sequestered in mitochondria [18], and possibly in
other intracellular compartments, and can bind to many intracellular
ligands.
The mechanisms of cellular Mn efﬂux are largely undeﬁned, al-
though given the overlap with Fe uptake transporters, it is possible
that Mn and Fe may also share efﬂux transport mechanisms. Thus,
one possibility is that Mn efﬂux is mediated by ferroportin (FPN1/
SLC40A1), a major mediator of iron release [19]. Ferroportin was
reported independently by three groups [20–22] and appears to
transport iron in the ferrous form, although this has not been
shown directly. To date, the energy source and the role of other ions
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mation is available on FPN1's transport kinetics or substrate speciﬁc-
ity [23]. This lack of this critical data can be explained in large part by
the technical difﬁculties that are inherent in studying metal efﬂux
transporters. First, efﬂux measurements require that the metal sub-
strates somehow be loaded inside the cells or oocytes, and that they
be loaded in the appropriate chemical form and concentration. This
can be attempted by loading with a known plasma membrane uptake
transporter, or by direct microinjection of the metal into the cell, but
neither of these approaches will ensure that the metal will be in the
appropriate chemical form, concentration, or localization within the
cell. Second, once metals are delivered or taken up into cells, they
can bind to many ligands and can be sequestered into various organ-
elles, making it impossible to accurately assess intracellular concen-
trations of the transportable species, which are presumably the free
divalent cations that are localized near the plasma membrane.
Third, the exogenous radiolabeled metals will be diluted by unlabeled
endogenous metals, further complicating the assessment of intracel-
lular metal concentrations and chemical activities. Furthermore, the
overexpression of FPN1 seems to be toxic to cells in culture, hamper-
ing the generation of stable cell lines [23]. Overall, these technical dif-
ﬁculties have made it, and will continue to make it extremely
challenging to elucidate the kinetics and energetics of metal efﬂux
from cells.
Interestingly, FPN1 is expressed in tissues involved in both iron
and manganese homeostasis, including the developing and mature
reticuloendothelial system, the duodenum, liver, and the pregnant
uterus [20,24]. FPN1 has also been identiﬁed in cells of the central
nervous system including those of the blood–brain barrier, choroids
plexus, neurons, oligodendrocytes, astrocytes, and retina [25,26].
FPN1 is localized to the basolateral membrane of duodenal epithelial
cells, and its overexpression in cultured cells results in intracellular
iron depletion. Recently, Yin and colleagues [27] have implicated
FPN1 as a potential Mn transporter. Using inducible HEK293T cell
model, they showed that FPN1 expression reducedMn-induced toxic-
ity and decreased Mn accumulation. In addition, Mn was also able to
increase FPN1 levels in native HEK cells and Fpn1 levels in mouse cer-
ebellum and cortex. An increase in Fpn1 mRNA levels in response to
Mn treatment was also seen by Troadec et al. [28].
To establish whether Mn is indeed a substrate for FPN1, and to
gain insight into FPN1 mediated transport mechanism, the present
study utilized Xenopus laevis oocytes injected with human FPN1
cRNA. The results demonstrate that Mn is a substrate for FPN1, and
thus suggest that this transporter may contribute to Mn homeostasis.
2. Materials and methods
2.1. Reagents
54MnCl2 (777.91 mCi/mg) and 55FeCl3 (25.04 mCi/mg) were pur-
chased from Perkin-Elmer Life and Analytical Sciences (Boston, MA).
Other chemicals and reagents were obtained from Sigma-Aldrich
Chemical Co. (St. Louis, MO) or J. T. Baker (Phillipsburg, NJ). Molecular
biology reagents were purchased from Invitrogen (Carlsbad, CA); Clon-
tech (Palo Alto, CA); Integrated DNA Technologies (Coralville, IA); Qia-
gen (Valencia, CA); Origene (Rockville, MD); Ambion (Austin, TX); and
Promega (Madison, WI). Mature female X. laevis were purchased from
Nasco (Fort Atkinson, WI). Animals were maintained under a constant
light/dark cycle. Experiments were conducted in accordance with the
guidelines of the NIH for care of laboratory animals.
2.2. Synthesis of cRNA
The full-length cDNA for human DMT1A was cloned from HepG2
cDNA, while FPN1 cDNA was obtained from ATCC (Manassas, VA). Se-
quences were sub-cloned into the pSP64 poly A vector (Clontech,Mountain View, CA). Of the four isoforms of DMT1, DMT1A+IRE
was chosen for these studies, as it demonstrates the most robust up-
take of Fe when expressed in Xenopus oocytes [29]. A c-Myc epitope
tag was added to the C-terminus of FPN1. End sequencing was per-
formed at the University of Rochester Functional Genomics Center
to verify clone identity and orientation. Capped cRNA was transcribed
in vitro using SP6 mMESSAGE mMACHINE kit (Ambion, Austin, TX).
cRNAs were precipitated with lithium chloride, resuspended in
RNase-free water, and stored at −80 °C until used for oocyte
microinjection.
2.3. Isolation and injection of Xenopus oocytes
Isolation of oocytes was performed as described by Goldin [30]
and previously employed in our laboratory [31,32]. Frogs were anes-
thetized by immersion for 15–20 min in ice-cold 0.3% tricaine. Oo-
cytes were removed from the ovary and washed with calcium-free
OR-2 solution (82.5 mM NaCl, 2 mM KCl, 1 mM MgCl2, and 5 mM
HEPES–Tris; pH 7.5) and incubated at room temperature with gentle
shaking for 80 min in OR-2 solution containing 1 mg/ml collagenase
(type IA, Sigma). Oocytes were transferred to fresh collagenase solu-
tion after the ﬁrst 40 min. Collagenase was removed by washing
with OR-2 solution at room temperature. Defolliculated stage V and
VI oocytes were selected and incubated at 18 °C in modiﬁed Barth's
solution [88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3, 0.82 mM MgSO4,
0.33 mM Ca (NO3)2, 0.41 mM CaCl2, and 20 mM HEPES–Tris (pH
7.4)]. After 30 min of incubation, oocytes were injected with 50 nl of
DMT1A or FPN1 cRNA (10 ng each cRNA/oocyte), or a combination of
both cRNAs (10 ng each cRNA/oocyte, 20 ng total cRNA), or sterile
water. Glass micropipettes with a tip diameter of 20–40 μm were
pulled on a Sutter Instrument model P80 pipette puller (Novato,
CA). A Drummond (Broomall, PA) microinjector attached to a Brink-
mann (Westbury, NY) MM33 micromanipulator was used for injec-
tion. Injected oocytes were cultured at 18 °C with a daily change of
modiﬁed Barth's media containing gentamycin (0.05 mg/ml), sodium
pyruvate (0.55 mg/ml), and theophylline (0.09 mg/ml). Oocytes with
a homogeneous brown animal half and distinct equator line were se-
lected for transport experiments after 3 days.
2.4. Uptake of 54Mn
For uptake measurements, six to ten oocytes were incubated at
25 °C for 2 or 6 h with 400 μl of modiﬁed Barth's solution containing
1 or 500 μM 54MnCl2 at pH 5.5 or 7.4, similar to those used by Yin
and colleagues [27]. Uptake was stopped by transferring the oocytes
to 2 ml of ice-cold modiﬁed Barth's solution containing 50 μM
MnCl2, and washed three times each with 2 ml of ice-cold modiﬁed
Barth's solution. Two oocytes were placed in a polypropylene scintil-
lation vial and were dissolved with 0.2 ml of 10% (w:v) SDS. Radioiso-
tope was counted in a Beckman model 6500 scintillation counter
(Fullerton, CA) after addition of 5 ml of Opti-Fluor (Packard Instru-
ments, Downers Grove, IL). The Mn concentrations were selected
based on previously measuredMn levels in mammalian blood and tis-
sues [4,5], and based on intracellular levels in oocytes [this work].
2.5. Efﬂux of 54Mn or 55Fe
Healthy oocytes were injected with 50 nl of isotope solution
(0.1 μCi/μl), containing various concentrations of 55FeSO4 or 54MnCl2
and inhibitors (see legends of Figs. 3–6 for individual composition).
55Fe solutions contained 1 mMascorbic acid to keep the Fe in a reduced
state [22,23]. Intracellular concentration of substrates was calculated
assuming an intracellular water space of 0.5 μl/oocyte for stage V and
VI oocytes with a diameter of 1.0–1.3 mm [30]. After a 10–30-min
pre-incubation at room temperature inmodiﬁed Barth solution, oocytes
were washed in 2.5 ml of modiﬁed Barth's solution to remove
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Fig. 1. FPN1-expressing oocytes demonstrate higher 55Fe and 54Mn efﬂux. Isolated Xeno-
pus oocyteswere injectedwith 10 ng FPN1 cRNA or H2O, and incubated for 3 days. Oocytes
(6–10) were washedwithmodiﬁed Barth's solution (MB), and then injectedwith 50 nl of
an 11 or 176 μM 55FeSO4 (A) or 54MnCl2 (B) solutions (ﬁnal intracellular concentrations of
approximately 1 and 16 μM), and allowed to recover for 10–30 min at room temperature.
Oocytes were then placed individually in vials, 200 μl of freshMB (pH 7.4) was added, and
incubated for 4 h. The incubation media were removed and the oocytes lysed with 10%
SDS. Both the media and oocyte were then counted. Data are presented as the mean of
55Fe or 54Mn released per oocyte in 4 h+SEM. *pb0.05 vs H2O (control).
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polypropylene scintillation vials in 200 μl of modiﬁed Barth's solution
(20 mM Hepes pH, 7.4; 20 mM Hepes pH 8.5; 20 mM MES pH 5.5; or
20 mM Hepes high K, where the NaCl was replaced by KCl, pH 7.4). In
some experiments, 500 μM Mn or Fe was added to the media. Efﬂux
wasmeasured for 30 min or 4 h at 25 °C. At the end of the efﬂux period,
the culture medium was removed and transferred to another scintilla-
tion vial, and the oocytes were dissolved in 0.2 ml of 10% SDS. Both
the culture medium and oocytes were counted in a Beckman model
6500 scintillation counter (Fullerton, CA) after addition of 5 ml of
Opti-Fluor (Packard Instruments, Downers Grove, IL). Efﬂux was
expressed as the amount of radioactivity recovered in the culturemedi-
umdivided by the total amount of radioactivity (i.e., the radioactivity in
the culture medium plus that remaining in the oocytes).
2.6. Determination of endogenous oocyte Mn content by atomic absorp-
tion spectrometry
Oocyte manganese concentrations were determined using a
Perkin-Elmer AAnalyst 600 atomic absorption spectrophotometer
equipped with longitudinal Zeeman background correction and a
transverse heated graphite furnace (Perkin-Elmer Life and Analytical
Sciences, Shelton, CT). The matrix modiﬁers, palladium nitrate
(5 μg) and magnesium nitrate (3 μg) were used to stabilize manga-
nese during the pyrolysis furnace step. Argon was used to protect
and purge the end capped graphite tubes with an internal ﬂow of
250 ml/min. A Perkin-Elmer Lumina hollow cathode lamp was used.
The spectrometer settings were: wavelength, 279.5 nm; slit width,
0.2 nm; Cu lamp current, 20 mA; background correction, Zeeman-
effect; integration time, 4 s; injection volume, 15 μl; and matrix mod-
iﬁer volume, 5 μl. The AA600 furnace thermal program was: Dry1,
100°C, ramp time 1 s, hold time 20 s; Dry2, 150°C, ramp time 15 s,
hold time 30 s; pyrolysis, 1300 °C, ramp time 10 s, hold time 20 s; at-
omization, 2000 °C, ramp time 0 s, hold time 4 s; clean out, 2450 °C,
ramp time 1 s, hold time 3 s. Oocyte samples were wet ashed with
ultra pure nitric acid (SeaStar Chemicals Inc., Sidney, BC, Canada).
The residue was dissolved in a small volume of concentrated nitric
acid and then diluted to 2% nitric acid with 18 mOhm deionized
water prior to analysis.
2.7. Isolation of membrane-enriched oocyte fractions and protein
analysis
The procedure for isolating membrane-enriched oocyte fractions
was adapted from Geering et al. [33] and Cattori et al. [34]. Oocytes
(100) were added to 2.5 ml ice-cold buffer containing 83 mM NaCl,
10 mM HEPES (N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic
acid; pH 7.4), 1 mM MgCl2, 25 μl/ml protease inhibitor cocktail
(Sigma P-8340), 1 mM phenylmethylsulfonyl ﬂuoride, and 5 mM
EDTA and homogenized with 20 strokes of a Dounce homogenizer
(type A, loose-ﬁtting pestle) immersed in ice. Samples were centri-
fuged twice at 1000 g at 4 °C for 10 min to remove yolk granules,
and the resulting supernatant was centrifuged at 15,000 g at 4 °C for
1 h. The pellet (membrane-enriched fraction) was resuspended in
100 μl of buffer containing 10 mM Tris–HCl (pH 7.4), 50 mM NaCl,
50 mM NaF, 10 μl/ml protease inhibitor cocktail, 5 mM EDTA, 1 mM
phenylmethylsulfonylﬂuoride and 1% Triton-X 100. The membrane-
enriched fractions were stored at −20 °C until use. The protein con-
centration of each sample was determined using the DC Protein
assay kit (Bio-Rad, Hercules, CA).
For immunoblot analysis of oocyte membrane-enriched fractions,
samples were dissolved in Laemmli buffer (1:1, Bio-Rad), and SDS-
PAGE was performed on 4–20% TGX Gels (Bio-Rad). For immunoblot-
ting, proteins were electrophoretically transferred onto polyvinyli-
dine ﬂuoride membranes, blocked overnight with 5% nonfat milk in
TBST [10 mM Tris–HCl (pH 8.0), 150 mM NaCl, and 0.05% (vol/vol)Tween-20] at 4 °C, and probed with the appropriate antibody in 5%
nonfat milk in TBST for 2 h at room temperature. For detection of
DMT1A, FPN1, and actin, primary antibodies against DMT1 (Sigma
WH0004891M1), c-MYC (Sigma M4439), and actin (Sigma A2066),
were each used at a dilution of 1:1000 (DMT1 and actin) or 1:500
(c-Myc). Blots were then probed with a peroxidase-linked secondary
antibody, anti-mouse immunoglobulin G from rabbit (Sigma A9044)
or anti-rabbit immunoglobulin G horseradish peroxidase-linked F
(ab)2 fragment from donkey (GE Healthcare, Buckinghamshire, UK),
in 5% nonfat milk in TBST for 1 h at room temperature. Antibody bind-
ing was then detected using an enhanced chemiluminescence tech-
nique (Perkin-Elmer, Waltham, MA).
2.8. Statistical analysis
Data were analyzed by ANOVA, and the two-tailed Student's t test
was used for comparisons with a control. Pb0.05 was considered sta-
tistically signiﬁcant. Data are expressed as means±SEM of three or
more independent experiments.
3. Results
To conﬁrm the function of FPN1 in our model system, Xenopus
oocytes that had been injected with cRNA for FPN1-c-Myc or H2O as
a control were subsequently microinjected with 55FeSO4 to achieve
intracellular concentrations of approximately 1 and 16 μM, and efﬂux
wasmeasured for 4 h at pH 7.4 (Fig. 1A). As expected [19–22], 55Fe ef-
ﬂux was negligible in control oocytes, but was markedly enhanced in
FPN1-injected oocytes (10.7±0.3% and 8.9±0.7% at 1 or 16 μM
55FeSO4, respectively; Fig. 1A), indicating that functional FPN1 was
being expressed in the oocytes.
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cant higher efﬂux of 54Mn, suggesting that Mn is also a substrate for
FPN1 (Fig. 1B). Note that whereas control oocytes released approxi-
mately 6% of the injected 54Mn over a 4 h interval, FPN1-expressing oo-
cytes released 20–25% of the 54Mn over the same time period, when
loaded with intracellular 54Mn concentrations of 1 or 16 μM (Fig. 1B).
To test whether Mn is indeed a substrate of FPN1, additional studies
were carried out in the Xenopus oocyte model. Oocytes were injected
with cRNA for FPN1-c-Myc, DMT1A, a combination of DMT1A and
FPN1-c-Myc, or H2O as control, and uptake of 54Mn for 2 or 6 hwas eval-
uated in the presence of 1 or 500 μMMnCl2 at pH5.5, the optimal pH for
DMT1A mediated uptake [8], or pH 7.4 (Fig. 2). At pH 7.4, 54Mn uptake
was negligible for all conditions testedwith 1 μM 54MnCl2 at both 2 and
6 h (Fig. 2A and C). At 2 h with 500 μM 54MnCl2, accumulation was
more pronounced compared to 1 μMMn in all conditions, but still was
not signiﬁcantly greater than the endogenous uptake observed in
water-injected oocytes (Fig. 2B). At 6 h, Mn accumulation was greater0
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Fig. 2. FPN1 co-expression can decrease DMT1A-mediated accumulation of 54Mn in a time an
of cRNA for FPN1, DMT1A, both FPN1 and DMT1, or H2O and incubated for 3 days. Oocytes (4–
containing 1 μM (A, C, E, G) or 500 μM (B, D, F, H) 54MnCl2 at 25 °C for 2 h (A, B, E, F) or 6 h
cold MB containing 50 μM cold MnCl2, lysed with 10% SDS and counted. Data are presentedthan control in the DMT1A injected and co-injected oocytes, most likely
due to the ability of DMT1 to have some transport activity at pH 7.4
[35,36]; however, these data did not reach the threshold of signiﬁcance
(Fig. 2D).
As expected, 54Mn uptake at pH 5.5 was robust in oocytes expres-
sing DMT1A (Fig. 2E–H). In contrast, in FPN1-c-Myc expressing
oocytes 54Mn uptake was similar to controls (Fig. 2E–H). When ex-
posed to 1 μMMn for 2 h, 54Mn accumulation was nearly identical be-
tween DMT1A alone and DMT1A+FPN1-c-Myc (8.4±0.5 and 8.7±
1.3 pmol/oocyte, respectively; Fig. 2E). Interestingly, at 6 h the co-
expression of FPN1 led to lower 54Mn accumulation versus DMT1A
alone (14.9±1.2 versus 9.8±0.6 pmol/oocyte). When exposed to
500 μM Mn (Fig. 2F and H), 54Mn accumulation was higher in
DMT1A expressing oocytes in both concentration and time depen-
dent manners. As seen at the 6 h time point with 1 μM Mn, co-
expression of FPN1 led to lower 54Mn accumulation at both 2 and
6 h (135±35 versus 58±15 and 230±14 versus 141±10 pmol/0
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Fig. 4. FPN1-expressing oocytes have higher 54Mn efﬂux, and efﬂux is concentration
dependent. Isolated Xenopus oocytes were injected with 10 ng FPN1 cRNA or H2O,
and incubated for 3 days. Oocytes (6–10) were washed with modiﬁed Barth's solution
(MB), and then injected with 50 nl of 54MnCl2 solutions to achieve ﬁnal intracellular
concentrations ranging from 16 to 830 μM, and allowed to recover for 10–30 min at
room temperature. Oocytes were then individually placed in vials, 200 μl of fresh MB
(pH 7.4) was added, and incubated for 4 h. The incubation media was removed and
the oocytes lysed with 10% SDS. Both the media and oocyte were then counted. Data
are presented as the mean of 54Mn released per oocyte in 4 h+SEM. *pb0.05 vs H2O
(control). FPN1-mediated efﬂux (dotted line) was calculated by subtracting the control
values from FPN1 values.
655M.S. Madejczyk, N. Ballatori / Biochimica et Biophysica Acta 1818 (2012) 651–657oocyte, respectively). These accumulation results suggest either that
DMT1-mediated uptake activity was diminished, or that FPN1 may
be acting as a Mn efﬂux transporter. The observations also suggest
that this Mn efﬂux mechanism is both time and concentration depen-
dent. In contrast, no signiﬁcant difference in 54Mn accumulation was
observed between control oocytes and oocytes expressing FPN1 at
any pH, time, or concentration tested, indicating that FPN1 is not
able to function as a Mn uptake transporter.
Western blots were performed to verify expression of DMT1A and
FPN1-c-Myc. Plasma membrane-enriched fractions were subject to
SDS-PAGE, and probed with either anti-DMT1 or anti-c-Myc anti-
bodies for detecting the FPN1-c-Myc polypeptide. DMT1 protein
was detected as multiple bands in DMT1A and DMT1A+FPN1 injected
oocytes, but was absent in control and FPN1 injected oocytes
(Fig. 3A). The major band was around 55 kDa, while staining was
also seen from approximately 60–100 kDa. These results are consis-
tent with those seen by Tabuchi et al. [37], who examined the expres-
sion of DMT1 isoforms in multiple cell lines. FPN1 was detected in
FPN1 and DMT1A + FNP1 injected oocytes as a band of 62–70 kDa,
consistent with results seen by McKie et al. [22], but was absent in
control and DMT1A injected oocytes (Fig. 3B). Note that DMT1A and
FPN1 expression levels appeared to be slightly lower in oocytes co-
expressing these proteins when compared to those expressing the in-
dividual transporters, possibly due to competition of the injected ex-
ogenous cRNAs for translation machinery. The apparent reduced
DMT1 expression may have contributed to the diminished Mn accu-
mulation noted in Fig. 2.
Thus, to test whether the lower Mn accumulation seen in oocytes
co-expressing DMT1A and FPN1 was actually due to the efﬂux of Mn
by FPN1, additional studies examined the ability of FPN1 to directly
export 54Mn. Control and FPN1 expressing oocytes were microin-
jected with increasing intracellular 54MnCl2 concentrations, and ef-
ﬂux was measured for 4 h at pH 7.4 (Fig. 4). FPN1 expressing
oocytes released more 54Mn at each concentration tested, and the
amount released was concentration dependent. When corrected for
the endogenous 54Mn efﬂux, the calculated FPN1-mediated efﬂux
was non-linear and suggested saturability (Fig. 4); however, for the
reasons noted in the Introduction section, these data are unsuitable
for calculating kinetic parameters.Fig. 3. Western blot analysis of Xenopus oocytes expressing human DMT1 and FPN1-c-Myc.
Xenopus oocyteswere injectedwith 10 ng of cRNA for FPN1,DMT1A, both FPN1 andDMT1, or
H2Oand incubated for 3 days. For immunoblot detection,membrane-enriched fractionswere
subject to SDS-PAGE. Blots were probed with primary antibodies against DMT1, c-Myc, and
actin, anddetectedwithhorseradishperoxidase-linked secondary antibodies. ForDMT1anal-
ysis (A), 10 μg of protein was used in each lane, and for FPN1 analysis 40 μg was used (B).Analysis of endogenous Mn levels in oocytes using atomic absorp-
tion spectroscopy revealed levels of 86±3 pmol/oocyte, or an ap-
proximate intracellular concentration of 173±6 μM assuming an
intracellular water volume of 0.5 μl/oocyte; however, this technique
only allowed for the determination of total Mn and not free Mn2+.
Because Mn can be sequestered into intracellular organelles such as
the mitochondria [18], the injected concentrations provide only esti-
mates of total Mn concentrations.
To examine the speciﬁcity of 54Mn efﬂux via FPN1, other metals
were co-injected with the 54MnCl2 (Fig. 5). Competing metals were
injected to an estimated intracellular concentration of 100 μM,
while 54MnCl2 was injected to 16 μM. Higher concentrations of metals
were not used in order to avoid toxicity to the oocytes. Even at this
low M(2)+ to Mn ratio (approximately 6:1), Fe2+, Co2+, and Ni2+
were all able to signiﬁcantly cis-inhibit 54Mn efﬂux via FPN1, whereas
Zn2+, Pb2+, Cd2+, and the monovalent Rb+ had no effect, suggesting
that FPN1 may be able to transport different divalent metals with dif-
fering afﬁnities.
To gain insight into the potential driving force for transport on
FPN1, efﬂux was compared at pH values of 5.5, 7.4, and 8.5
(Fig. 6A). At all three pH values, FPN1 mediated 54Mn efﬂux was0
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Fig. 5. FPN1-mediated 54Mn efﬂux is cis-inhibited by Fe, Co, and Ni. Isolated Xenopus
oocytes were injected with 10 ng FPN1 cRNA or H2O, and incubated for 3 days. Oocytes
(6–10) were washed with modiﬁed Barth's solution (MB), and then injected with 50 nl
of a 176 μM 54MnCl2 solution alone or co-injected with 1.1 mM of the indicated metals
(ﬁnal intracellular concentration of approximately 16 μM for 54Mn and 100 μM for the
other metals) and allowed to recover for 10–30 min at room temperature. Oocytes
were then individually placed in vials, 200 μl of fresh MB (pH 7.4) was added, and in-
cubated for 4 h. The incubation media were removed and the oocytes lysed with 10%
SDS. Both the media and oocyte were then counted. Data are presented as the mean
of 54Mn released per oocyte in 4 h+SEM. *pb0.05 vs control.
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Fig. 7. FPN1-mediated 54Mn efﬂux is trans-inhibited by extracellular Fe and Ni. Isolated
Xenopus oocytes were injected with 10 ng FPN1 cRNA or H2O, and incubated for 3 days.
Oocytes (6–10) were washed with modiﬁed Barth's solution (MB), and then injected
with 50 nl of a 176 μM 54MnCl2 solution (ﬁnal intracellular concentration of approxi-
mately 16 μM) and allowed to recover for 10–30 min at room temperature. Oocytes
were then individually placed in vials, 200 μl of fresh MB (pH 7.4) alone or with
500 μM Fe, Mn, or Ni was added, and incubated for 30 min. The incubation media
were removed and the oocytes lysed with 10% SDS. Both the media and oocyte were
then counted. Data are presented as the mean percent of 54Mn released per oocyte in
4 h or 30 min+SEM. *pb0.05 vs H2O, †pb0.05 vs control.
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but not 8.5, Mn efﬂux was signiﬁcantly lower than at pH 7.4. This in-
dicates the potential role for an outward proton gradient as a driving
force for Mn efﬂux via FPN1. In addition, efﬂux was examined in a
high K+ media to depolarize the cell membrane potential (Fig. 6B).
In the high K+ media, FPN1 mediated Mn efﬂux was about one-
third lower (18.8±1.2% versus 26.6±0.6% efﬂux in 4 h, respectively),
indicating that the membrane potential or the Na+ or K+ gradients
may also inﬂuence FPN1-mediated Mn export.
To further explore the mechanism of transport, trans-stimulation
experiments were performed in which 54Mn efﬂux was measured in
media containing 500 μM Fe, Ni, or unlabeled Mn (Fig. 7). However,
these metals were unable to stimulate 54Mn efﬂux, and in fact actual-
ly inhibited efﬂux, with Ni being able to fully inhibit 54Mn efﬂux
(Fig. 7), indicating trans-inhibition of efﬂux. The mechanism for this
trans-inhibition is as yet undeﬁned, but it provides additional evi-
dence that Mn is a substrate for FPN1.
4. Discussion
The present results provide direct evidence that Mn is a substrate
for FPN1, and provide clues as to FPN1's transport mechanism. In par-
ticular, FPN1 mediated transport appears to be unidirectional, and is
inhibited at low pH and by the substitution of Na+ with K+ in the cul-
ture medium. This putative role of FPN1 in Mn export is consistent
with its cellular and subcellular localization. FPN1 is expressed in tis-
sues involved in both Fe and Mn homeostasis, including the develop-
ing and mature reticuloendothelial system, the duodenum, liver, and0
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Fig. 6. FPN1 mediated 54Mn efﬂux is inhibited in medium of low pH, or in which the
Na+ is substituted with K+. Isolated Xenopus oocytes were injected with 10 ng FPN1
cRNA or H2O, and incubated for 3 days. Oocytes (6–10) were washed with modiﬁed
Barth's solution (MB), and then injected with 50 nl of a 176 μM 54MnCl2 solution
(ﬁnal intracellular concentration of approximately 16 μM) and allowed to recover for
10–30 min at room temperature. Oocytes were then individually placed in vials con-
taining either: A. 200 μl of fresh MB (pH 5.5, 7.4, or 8.5), or B. 200 μl of fresh MB (pH
7.4) or high K+ MB, and incubated for 4 h. The incubation media were removed and
the oocytes lysed with 10% SDS. Both the media and oocyte were then counted. Data
are presented as the mean percent of 54Mn released per oocyte in 4 h+SEM.
*pb0.05 vs H2O (control), †pb0.05 vs FPN1 at either pH 5.5 (panel A), or vs FPN1 in
control media (panel B).the pregnant uterus [20,24], as well as cells of the central nervous sys-
tem, including those of the blood–brain barrier, choroids plexus, neu-
rons, oligodendrocytes, astrocytes, and retina [25,26]. FPN1 is
localized to the basolateral membrane of the duodenal epithelial
cells, where it acts in concert with DMT1 to mediate the trans-
cellular movement of Fe, and possibly Mn, from the intestinal lumen
into the blood. Mutations in FPN1 lead to a form of hemochromatosis
known as “ferroportin disease,” which is characterized by a progres-
sive iron accumulation in organs, predominantly in reticuloendotheli-
al macrophages [38], while deletion is embryonically lethal [19].
The present results demonstrate that oocytes expressing FPN1 are
able to release nearly four-fold as much 54Mn as control oocytes
(Fig. 1). Further analysis demonstrated that the efﬂux was concentra-
tion dependent (Fig. 4), and appeared to be saturable, but kinetic pa-
rameters could not be calculated for this export mechanism for the
reasons described in the Introduction section. Additional evidence
that Mn is indeed a substrate for FPN1 comes from the ﬁnding that
Mn efﬂux could be cis-inhibited by divalent Fe, Co, and Ni. Even
though the excess of injected metals was modest (approximately
6:1), there was a 15–40% inhibition of Mn efﬂux, with Ni having the
greatest effect (Fig. 5). It is not surprising that these other metals
may also be substrates for FPN1, as they are similar both structurally
and chemically. The Arabadopsis orthologues of human FPN1 appear
to be involved in both Fe and Co homeostasis [39], also indicating a
broad metal substrate speciﬁcity for this FPN1 orthologue. Taken to-
gether, these data provide strong evidence that Mn is indeed a sub-
strate for FPN1.
Insight into the mechanism of FPN1-mediated transport was
obtained by examining whether extracellular pH had an effect on ef-
ﬂux. FPN1-mediated Mn efﬂux was robust and similar between pH
7.4 and 8.5; however, it was signiﬁcantly decreased at pH 5.5, sug-
gesting that the H+ gradient from in to out may be a part of the driv-
ing force for efﬂux. In addition to the proton gradient, other ion
gradients may also play a role. Incubation in high K+ media resulted
in a decrease in Mn efﬂux, indicating that Mn efﬂux via FPN1 may be
dependent on the membrane potential or on the Na+ or K+ gradients.
In contrast to the ability of FPN1 to mediate Mn export, this pro-
tein had no effect on Mn uptake in cells incubated with either 1 or
500 μM Mn, at pH 5.5 or 7.4 (Fig. 2). This indicates that transport
via FPN1 is unidirectional, and is supported by the results of McKie
et al., [22] who reported no Fe uptake via FPN1 when expressed in
Xenopus oocytes. Interestingly, Ni was able to cis-inhibit (Fig. 5) and
trans-inhibit (Fig. 7) Mn efﬂux. The reason for this is unknown, but
one possible explanation is that Ni may bind with high afﬁnity to
both the inward- and outward-facing conformations of FPN1, thus
657M.S. Madejczyk, N. Ballatori / Biochimica et Biophysica Acta 1818 (2012) 651–657inhibiting export from both the intracellular and extracellular faces of
the protein.
In summary, the present study provides direct evidence that Mn is
a substrate for FPN1, and suggests that FPN1 may be a multi-speciﬁc
metal efﬂux carrier. Transport via FPN1 is reduced by both low pH
and by substituting K+ for Na+ in the culture medium, suggesting
that transmembrane ion or electrical gradients inﬂuence transport
activity; however, additional research is needed to further character-
ize the substrate speciﬁcity and driving force for FPN1. Although both
Fe andMn appear to be well transported in this model system (Fig. 1),
due to the challenges to studying efﬂux mentioned earlier, it is difﬁ-
cult to speculate on their relative afﬁnities for the transporter. The
conclusion that Mn and Fe share a mechanism for efﬂux provides ad-
ditional insight into the interplay between iron and manganese ab-
sorption and toxicity, and suggests that FPN1 may be a target for
modifying cellular levels of these metals. It is well established that
iron deﬁciency is a risk factor for increased manganese absorption
in the gut (Heilig et al., for a review [40]), and DMT1 mRNA levels
are dramatically upregulated in enterocytes of iron-deﬁcient rats
[8]. As Mn levels rise in the cell, FPN1 may be up regulated in re-
sponse [27,28], and this enhanced FPN1 expression could stimulate
Mn absorption into the bloodstream. Additional studies are needed
to test this model, and to establish the physiological relevance of
FPN1 to Mn absorption.
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